There's a hedge fund out there buying the stock to take over the company. It's valued for less than sales and the IP is valuable.
This is where you back the truck up.
There is $70 million in cash here. Phase II completed companies with big market drugs rarely sell for under $250M
I don't see that. Lilly has some problems ($9B) now with a mess-up trial on insulin.
You are on the money. The trial was also on a much larger dose of a drug that has already been proven safe. My bet is Roche or Baxter take advantage of this and buy the company. This company has a library of technology that I can say is too valuable.
Are you nuts ? This is now an enormous opportunity for one of its partners to just buy them. And if they do it is going to be north of $2.5B. HALO is the leader in enzyme technology with a portfolio of technology that represents huge value to any major drug company. The smart money is loading up at these levels.
You are not the brightest bulb are you. Do some homework. HALO os a bargain at these levels. Any body with a history in biotech investing could figure this out.
Seeking Alfa is a bucket-shop used to manipulate stocks. I have been banned from posting educated rebuttals based on claims that I have "dismissed the writer" with well researched facts. Seeking Alfa hides behind their ghost writer clause but the SEC is on to them. Anyone who reads their nonsense deserves what they get.
Answered. Noble is a boiler-room penny stock operation out of Boca Raton FL. The analyst is a fellow named Nathan Cali who's background is questionable . Checks with the street indicate he knows little about the industry or finance.
Obviously he knows little about the industry or has any concept in value. Is this a joke ?
What they fail to point out is GEO is priming to go public (though not through Deutsche). CEO Paul Russo is the gorilla in the room. AMBA will need some leadership to compete against this industry veteran.
AMBA reminds me of JDSU in 2001. Every body was comparing its value to the PE of comps and no one realized that the PEs were all out of line. The chip business is like the diagnostics business......there is some else that will soon come along with a faster, better product and suddenly your margins shrink as your old inventory swells. This all happens while everyone is waiting for the market to develop which then happens slower than expected. This is a company that, despite its good products, faces formidable competition, yet is being priced like it has none. My guess (and it is a guess as hype has a way of sticking around longer than you expect) is that we will be able to buy this company below $23 in the not too distant future. Cracks are already beginning to appear in the fundamentals as margins are beginning to be squeezed a bit. The hype with respect to cameras needs to wain. But what confuses me is how no one was willing to touch this on the offering last year. As someone long the company in a big way back then - it baffles me. Do we really have young fools running the public portfolios of mutual funds these days ?
The company that presently owns the auto market (and most other markets) with equal capability
Come now. Use your head. Google is a consumer driven - value added company. They buy a Nest. They buy a Waze. Something the consumer uses directly or purchases. They are not going to buy a commodity business that sells to a few customers. The idea that Google would buy this is silly.
Not a chance. GEO has most of the markets wrapped up. There is not an engineer in the auto game that is going away from GEO